Patel V, Joharapurkar A, Dhanesha N, Kshirsagar S, Patel K, Bahekar R, et al
As research evolves, clinicians who understand the underlying biology today will be better equipped to apply tomorrows evidence responsibly
If too much time has passed, skip and resume on your next scheduled day
Our dedication to quality control ensures consistency and purity in every bottle
Many patients on GLP-1 medications lose an average of 10% to 15% of their body weight over 12-18 months, depending on their body mass index, dose, and adherence to a treatment plan
Routine measurement of serum calcitonin or thyroid ultrasound surveillance is not recommended for the general population of patients prescribed tirzepatide, as these screening approaches have poor positive predictive value and may lead to unnecessary interventions in patients with benign findings